177 related articles for article (PubMed ID: 17709970)
1. A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals.
Ponzoni M; Kwee I; Mazzucchelli L; Ferreri AJ; Zucca E; Doglioni C; Cavalli F; Bertoni F
Pathobiology; 2007; 74(4):264-9. PubMed ID: 17709970
[TBL] [Abstract][Full Text] [Related]
2. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma.
Freilich RJ; DeAngelis LM
Neurol Clin; 1995 Nov; 13(4):901-14. PubMed ID: 8584003
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
5. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
[TBL] [Abstract][Full Text] [Related]
6. Treatment of primary central nervous system lymphoma.
Shah GD; DeAngelis LM
Hematol Oncol Clin North Am; 2005 Aug; 19(4):611-27, v. PubMed ID: 16083826
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
8. [Response to chemotherapy in cerebral primary lymphoma].
García-Rayo S; Martínez-Monge R; Brugarolas A
Rev Neurol; 1998 Dec; 27(160):992-4. PubMed ID: 9951022
[TBL] [Abstract][Full Text] [Related]
9. Management of immunocompetent patients with primary central nervous system lymphoma.
Chimienti E; Spina M; Vaccher E; Tirelli U
Clin Lymphoma Myeloma; 2009 Oct; 9(5):353-64. PubMed ID: 19858054
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: experience of 46 cases with review of literature.
Tiwari MK; Singh DP; Pathak A; Khandelwal N; Radotra BD; Mathuriya SN; Gupta SK; Khosla VK; Sharma BS; Kak VK
Neurol India; 2002 Dec; 50(4):424-9. PubMed ID: 12577089
[TBL] [Abstract][Full Text] [Related]
11. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
Reni M; Ferreri AJ
Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.
Porter AB; Giannini C; Kaufmann T; Lucchinetti CF; Wu W; Decker PA; Atkinson JL; O'Neill BP
Ann Neurol; 2008 May; 63(5):662-7. PubMed ID: 18481293
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-Myc in primary central nervous system lymphoma of Thais.
Assanasen T; Shuangshoti S; Nilyai S; Wannakrairot P; Ruangvejvorachai P; Sawatdee R; Sangprakarn S
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S40-6. PubMed ID: 17718267
[TBL] [Abstract][Full Text] [Related]
16. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features.
Sutherland T; Yap K; Liew E; Tartaglia C; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Jun; 56(3):295-301. PubMed ID: 22697326
[TBL] [Abstract][Full Text] [Related]
19. [Primary cerebral lymphoma in an immunocompetent patient].
García ME; García AM; Catalán MJ
Neurologia; 2008 Mar; 23(2):122-5. PubMed ID: 18322833
[TBL] [Abstract][Full Text] [Related]
20. Primary CNS lymphoma in immunocompetent patients.
Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
